Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(updated broken publication link) |
(removed commas) |
||
Line 1: | Line 1: | ||
{| style="margin: 10px; background-color:#efefef" | {| style="margin: 10px; background-color:#efefef" | ||
|width=100px; cell padding=50px|{{#pwImage:Pathway:WP2583|250px||T-Cell Receptor and Co-stimulatory Signaling}} | |width=100px; cell padding=50px|{{#pwImage:Pathway:WP2583|250px||T-Cell Receptor and Co-stimulatory Signaling}} | ||
- | [http://dx.doi.org/10.1002/hep.27043 Takahashi | + | [http://dx.doi.org/10.1002/hep.27043 Takahashi et al. Long non-coding RNA in liver diseases] |
|width=100px|{{#pwImage:Pathway:WP2865|250px||IL1 and megakaryotyces in obesity}} | |width=100px|{{#pwImage:Pathway:WP2865|250px||IL1 and megakaryotyces in obesity}} | ||
- | [http://dx.doi.org/10.1161/ATVBAHA.113.302700 Beaulieu | + | [http://dx.doi.org/10.1161/ATVBAHA.113.302700 Beaulieu et al. Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans] |
|width=100px|{{#pwImage:Pathway:WP2805|250px||RNA interference}} | |width=100px|{{#pwImage:Pathway:WP2805|250px||RNA interference}} | ||
- | [http://dx.doi.org/10.1016/j.addr.2013.12.008 Ozpolat | + | [http://dx.doi.org/10.1016/j.addr.2013.12.008 Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy] |
- | [http://dx.doi.org/10.1016/j.tig.2014.05.003 Thomas | + | [http://dx.doi.org/10.1016/j.tig.2014.05.003 Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways] |
|width=100px|{{#pwImage:Pathway:WP2870|250px||Extracellular vesicle-mediated signaling in recipient cells}} | |width=100px|{{#pwImage:Pathway:WP2870|250px||Extracellular vesicle-mediated signaling in recipient cells}} | ||
- | [http://www.ncbi.nlm.nih.gov/pubmed/25307053 Gangoda | + | [http://www.ncbi.nlm.nih.gov/pubmed/25307053 Gangoda et al. Extracellular vesicles including exosomes are mediators of signal transduction: Are they protective or pathogenic?] |
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | |width=100px|{{#pwImage:Pathway:WP2868|250px||TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer}} | ||
- | [http://dx.doi.org/10.1002/msb.20134892 Yang | + | [http://dx.doi.org/10.1002/msb.20134892 Yang et al. Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer] |
|width=100px|{{#pwImage:Pathway:WP2866|250px||mir34a and TGIF2 in osteoclastogenesis}} | |width=100px|{{#pwImage:Pathway:WP2866|250px||mir34a and TGIF2 in osteoclastogenesis}} | ||
- | [http://dx.doi.org/10.1038/nature13375 Krzeszinski | + | [http://dx.doi.org/10.1038/nature13375 Krzeszinski et al. miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2] |
|width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | |width=100px|{{#pwImage:Pathway:WP2811|250px||mir219 in Oligodendrocyte Differentiation and Myelination}} | ||
- | [http://dx.doi.org/10.1002/glia.22606 Pusic | + | [http://dx.doi.org/10.1002/glia.22606 Pusic et al. Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination] |
|width=100px|{{#pwImage:Pathway:WP2864|250px||Apoptosis-related network due to altered Notch3 in ovarian cancer}} | |width=100px|{{#pwImage:Pathway:WP2864|250px||Apoptosis-related network due to altered Notch3 in ovarian cancer}} | ||
- | [http://dx.doi.org/10.1158/0008-5472.CAN-13-2066 Hu | + | [http://dx.doi.org/10.1158/0008-5472.CAN-13-2066 Hu et al. Notch3 pathway alterations in ovarian cancer] |
|- | |- | ||
|width=100px|{{#pwimage:Pathway:WP2928|250px||miR-222 in Exercise-Induced Cardiac Growth}} | |width=100px|{{#pwimage:Pathway:WP2928|250px||miR-222 in Exercise-Induced Cardiac Growth}} | ||
- | [http://dx.doi.org/10.1016/j.cmet.2015.02.014 Liu | + | [http://dx.doi.org/10.1016/j.cmet.2015.02.014 Liu et al. miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling] |
|width=100px|{{#pwimage:Pathway:WP2943|250px||Hypoxia-mediated EMT and Stemness}} | |width=100px|{{#pwimage:Pathway:WP2943|250px||Hypoxia-mediated EMT and Stemness}} | ||
- | [http://dx.doi.org/10.1038/ncomms6203, van den Beucken | + | [http://dx.doi.org/10.1038/ncomms6203, van den Beucken et al. Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER] |
|width=100px|{{#pwimage:Pathway:WP2942|250px||DDX1 as a regulatory component of the Drosha microprocessor}} | |width=100px|{{#pwimage:Pathway:WP2942|250px||DDX1 as a regulatory component of the Drosha microprocessor}} | ||
- | [http://dx.doi.org/10.1016/j.celrep.2014.07.058, Han | + | [http://dx.doi.org/10.1016/j.celrep.2014.07.058, Han et al. The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression] |
|width=100px|{{#pwimage:Pathway:WP3297|250px||EV release from cardiac cells and their functional effects}} | |width=100px|{{#pwimage:Pathway:WP3297|250px||EV release from cardiac cells and their functional effects}} | ||
[http://www.ncbi.nlm.nih.gov/pubmed/25429310, Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future?] | [http://www.ncbi.nlm.nih.gov/pubmed/25429310, Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future?] |
Revision as of 17:31, 27 August 2015
Image does not exist |
Image does not exist |
Image does not exist Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future? |
Image does not exist Gonzalez-Villasana et al. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer |
Image does not exist Miyake et al. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |
Image does not exist |